Ikena Oncology, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Ikena Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
- Ikena Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$10.2M, a 41% increase year-over-year.
- Ikena Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$59.6M, a 5.06% increase year-over-year.
- Ikena Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$68.2M, a 0.87% increase from 2022.
- Ikena Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$68.8M, a 102% decline from 2021.
- Ikena Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$34.1M, a 22.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)